ibrutinib
Tyrosine Kinase Inhibitors
Common brand names
- Imbruvica
Approved use in
- Multiple Myeloma
- B-Cell Prolymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- T-Cell Prolymphocytic Leukemia
- Waldenström's Macroglobulinemia
Information about use in Blood Cancer
Information about use in B-Cell Prolymphocytic Leukemia
Information about use in Chronic Lymphocytic Leukemia
Information about use in Mantle Cell Lymphoma
Information about use in Marginal Zone Lymphoma
Information about use in T-Cell Prolymphocytic Leukemia
Information about use in Waldenström's Macroglobulinemia